Population
HepG2 cells
Design
Preclinical
Follow-up
2 hours
Authors
Loading...
Does not yet support HDL-targeted therapies; leaves open relevance of these pathways to human lipid metabolism.
Demonstrates that apoA-I is secreted from HepG2 cells in both lipid-poor and intracellularly lipidated forms, providing insight into early HDL assembly.
Chisholm et al. (2002) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: